BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 25203142)

  • 1. Monitoring of anticoagulant effects of dabigatran in everyday practice: first experience in 32 Polish patients.
    Czubek U; Góralczyk T; Zalewski J; Undas A
    Pol Arch Med Wewn; 2014; 124(9):487-9. PubMed ID: 25203142
    [No Abstract]   [Full Text] [Related]  

  • 2. [Hemodialysis to remove anticoagulant dabigatran during emergencies].
    Carrizo A; Campbell S
    Medicina (B Aires); 2014; 74(2):121-3. PubMed ID: 24736256
    [TBL] [Abstract][Full Text] [Related]  

  • 3. On the monitoring of dabigatran treatment in "real life" patients with atrial fibrillation.
    Skeppholm M; Hjemdahl P; Antovic JP; Muhrbeck J; Eintrei J; Rönquist-Nii Y; Pohanka A; Beck O; Malmström RE
    Thromb Res; 2014 Oct; 134(4):783-9. PubMed ID: 25172669
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Reversal of dabigatran with haemodialysis in a patient requiring decompression for cord compression from an epidural abscess.
    Lowe MP; Collins J; Yehia M; Eaddy N
    Nephrology (Carlton); 2013 Aug; 18(8):580-2. PubMed ID: 23865545
    [No Abstract]   [Full Text] [Related]  

  • 5. Measurement of dabigatran in standardly used clinical assays, whole blood viscoelastic coagulation, and thrombin generation assays.
    van Ryn J; Grottke O; Spronk H
    Clin Lab Med; 2014 Sep; 34(3):479-501. PubMed ID: 25168938
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Dabigatran in prevention of stroke in atrial fibrillation: three years of clinical application].
    Zotova IV; Zateĭshchikov DA
    Kardiologiia; 2014; 54(2):79-85. PubMed ID: 24888206
    [No Abstract]   [Full Text] [Related]  

  • 7. Dabigatran for the prevention of stroke in atrial fibrillation: is RE-LY reliable?
    Marín F; Roldán V; Lip GY
    Expert Opin Pharmacother; 2012 Jun; 13(8):1087-90. PubMed ID: 22568622
    [No Abstract]   [Full Text] [Related]  

  • 8. Public health. Change of heart.
    Taylor J
    Health Serv J; 2012 Jul; 122(6315):19-20. PubMed ID: 23155563
    [No Abstract]   [Full Text] [Related]  

  • 9. Dabigatran-induced acute hepatitis.
    Rochwerg B; Xenodemetropoulos T; Crowther M; Spyropoulos A
    Clin Appl Thromb Hemost; 2012 Sep; 18(5):549-50. PubMed ID: 22962308
    [No Abstract]   [Full Text] [Related]  

  • 10. [Dabigatran in the prevention of stroke in nonvalvular atrial fibrillation: complex clinical situations and real clinical practice].
    Tkacheva ON; Akasheva DU
    Ter Arkh; 2014; 86(4):103-7. PubMed ID: 24864477
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Contact with pharmacist can improve adherence to new anticoagulant, study finds.
    Kmietowicz Z
    BMJ; 2015 Apr; 350():h1954. PubMed ID: 25878142
    [No Abstract]   [Full Text] [Related]  

  • 12. Dabigatran use in a postoperative coronary artery bypass surgery patient with nonvalvular atrial fibrillation and heparin-PF4 antibodies.
    Fieland D; Taylor M
    Ann Pharmacother; 2012 Jan; 46(1):e3. PubMed ID: 22202498
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dabigatran for stroke prevention in all patients with atrial fibrillation?
    Hunchuck JE; Lake JD
    Pharmacotherapy; 2011 Aug; 31(8):725-8. PubMed ID: 21923597
    [No Abstract]   [Full Text] [Related]  

  • 14. Australian MPs demand more data on dabigatran for atrial fibrillation.
    Brill D
    BMJ; 2013 Jan; 346():f303. PubMed ID: 23321733
    [No Abstract]   [Full Text] [Related]  

  • 15. Benefits of dabigatran maintained for more than two years.
    Aalbers J
    Cardiovasc J Afr; 2012 Nov; 23(10):576. PubMed ID: 23192264
    [No Abstract]   [Full Text] [Related]  

  • 16. Dabigatran for stroke prevention in nonvalvular atrial fibrillation: focus in the geriatric population.
    Brunetti L; Chen C; White J
    Consult Pharm; 2014 Mar; 29(3):169-78. PubMed ID: 24589766
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dabigatran monitoring made simple?
    Eikelboom JW; Weitz JI
    Thromb Haemost; 2013 Sep; 110(3):393-5. PubMed ID: 23884303
    [No Abstract]   [Full Text] [Related]  

  • 18. [Expectation to and problems of thrombin inhibitor].
    Uchiyama S
    Rinsho Shinkeigaku; 2011 Nov; 51(11):1004-6. PubMed ID: 22277458
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Site-level variation in and practices associated with dabigatran adherence.
    Shore S; Ho PM; Lambert-Kerzner A; Glorioso TJ; Carey EP; Cunningham F; Longo L; Jackevicius C; Rose A; Turakhia MP
    JAMA; 2015 Apr; 313(14):1443-50. PubMed ID: 25871670
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Diffuse alveolar hemorrhage associated with dabigatran.
    Yokoi K; Isoda K; Kimura T; Adachi T
    Intern Med; 2012; 51(18):2667-8. PubMed ID: 22989848
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.